| Aug 6 |
Protagonist GAAP EPS of -$0.50 beats by $0.23, revenue of $4.17M misses by $2.5M
|
| Aug 6 |
Protagonist Therapeutics: Q2 Earnings Snapshot
|
| Aug 6 |
Protagonist Reports Second Quarter 2024 Financial Results and Provides Corporate Update
|
| Aug 1 |
RETRANSMISSION: Preclinical and Clinical Pharmacokinetic, Pharmacodynamic, and Safety Data of Targeted Oral Peptide JNJ-2113 Published in Scientific Reports
|
| Aug 1 |
Preclinical and Clinical Pharmacokinetic, Pharmacodynamic, and Safety Data of Targeted Oral Peptide JNJ-2113 Published in Scientific Reports
|
| Jul 28 |
ViaSat & AST SpaceMobile Are Among Top 6 Mid Cap Stocks That Shined The Brightest Last Week (July 21-July 27): Are The Others In Your Portfolio?
|
| Jul 22 |
Protagonist Therapeutics to Participate in the BTIG Virtual Biotechnology Conference 2024
|
| Jul 18 |
Protagonist Therapeutics (PTGX) is on the Move, Here's Why the Trend Could be Sustainable
|
| Jul 11 |
3 Growth Stocks No One Is Watching (But They Should Be)
|
| Jun 28 |
Protagonist Therapeutics Surges On Plans To Join S&P SmallCap 600
|
